The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Transdermal and Topical Delivery Systems - Product Development 1 and Quality Considerations



This guidance provides recommendations to applicants and manufacturers of transdermal and topical delivery systems (TDS)2 regarding the pharmaceutical development and quality information to include in new drug applications (NDAs) and abbreviated new drug applications (ANDAs).

Go back

GMP Conferences by Topics